Background {#Sec1}
==========

Infectious diseases including bacterial infections continue to be a serious health problem worldwide. Multidrug-resistant (MDR) pathogens considerably increase the mortality and morbidity. In effect, clinically, the continuous emergence of Gram-negative MDR bacteria drastically reduced the efficacy of antibiotic arsenal leading globally to an increase of the frequency of therapeutic failure (Rice [@CR44]). Consequently, new antibacterials are needed to fight these bacterial pathogens, but progress in developing them have been slow (Fischbach and Walsh [@CR12]). Plant kingdom represents an enormous source of new chemotherapeutic agents to tackle microbial infections. Several natural compounds belonging to the usual pharmaceutical library have been tested for their ability to combat resistant bacteria (Fischbach and Walsh [@CR12]; Saleem et al. [@CR45]). More than 450 natural metabolites with antimicrobial activity have been reported in the period 2000--2010 (Saleem et al. [@CR45]). Some of the best plant metabolites from African medicinal plants with antibacterial activity against MDR Gram-negative phenotypes include laurentixanthone B (xanthone), diospyrone and plumbagin (naphthoquinone), isobavachalcone and 4-hydroxylonchocarpin (flavonoids) and MAB3 (coumarin) (Kuete et al. [@CR21], [@CR22]). The rationale of this work comes to the fact that secondary metabolites belonging to terpenoids, phenolics and alkaloids previously displayed prominent antibacterial activity against MDR Gram-negative bacteria expressing active efflux pumps (Kuete et al. [@CR21], [@CR22]). Therefore, the present study was designed to determine the antibacterial activity of several molecules, including terpenoids, alkaloids, thiophenes and phenolics, against different bacterial strains expressing MDR phenotypes. Furthermore, we highlighted the possible pharmacophoric cores amongst the active compounds.

Results {#Sec2}
=======

Studied compounds {#Sec3}
-----------------

Compounds tested in the present study (Fig. [1](#Fig1){ref-type="fig"}) were previously or newly isolated from several Cameroonian plants. They include atalantoflavone (**1**; yellow solid; m.p. 286.2--287.7 °C) (Ouete et al. [@CR41]); 2′-hydroxyatalantoflavone (**2**; reddish gum) (Ouete et al. [@CR41]); neocyclomorusin (**3**; yellow solid, m.p. 263.2--266.7 °C) (Ouete et al. [@CR41]; Cho et al. [@CR7]); 2-(3,5-dihydroxyphenyl)benzofuran-5,6-diol (**4**; yellow oil) (Ouete et al. [@CR42]; Noguchi et al. [@CR39]); 4-hydroxy-2,6-di-(3′,4′-dimethoxyphenyl)-3,7-dioxabicyclo-(3.3.0)octane (**5**; yellow solid; m.p. 168.5--169.9 °C) (Kuete et al. [@CR24]); candidone (**6**; yellowish powder; m.p. 95.1--96.2 °C) (Ouete et al. [@CR41]; Kuete et al. [@CR24]); isoneorautenol (**7**; yellowish solid; m.p. 156.2--157.8 °C) (Nkengfack et al. [@CR38]; Kuete et al. [@CR25]); neobavaisoflavone (**8**; yellowish oil) (Nkengfack et al. [@CR37]; Kuete et al. [@CR25]); tecleaverdoornine (**9**; amorphous solid) (Ayafor and Okogun [@CR2]; Sandjo et al. [@CR46]); maculine (**10**; amorphous solid) (Nunes et al. [@CR40]; Kuete et al. [@CR19]; Sandjo et al. [@CR46]); deacetylnomilin (**11**; colorless oil) (Bennett and Hasegawa [@CR4]); daidzein (**12**; yellowish gum) (Basha et al. [@CR3]); isowighteone (**13**; yellowish gum) (Wang et al. [@CR51]); dorstenin (**14**; white solid; m.p. 136--139 °C) (Kuster et al. [@CR26]; Abegaz et al. [@CR1]); herranone (**15**; colorless solid; m.p. 285--287 °C) (Wiedemann et al. [@CR52]); isogarcinol (**16**; brown oil) (Marti et al. [@CR28]); 2-(penta-1,3-diynyl)-5-(3,4-dihydroxybut-1-ynyl)thiophene (**17**; brownish oil) (Shi et al. [@CR48]); ulmoside A (**18**; brown oil) (Rawat et al. [@CR43]) and 3,4,3′-tri-*O*-methylellagic acid (**19**; brown solid; m.p. 282--284 °C) (Gao et al. [@CR13]). These compounds belong to flavonoids (**1-3, 6, 18**), isoflavonoids (**7, 8, 12, 13**), benzophenone (**16**), benzofuran (**4**), ellagic acid derivative (**19**), lignan (**5**), alkaloids (**9, 10**), terpenoids (**11, 15**) and thiophene (**19**). They were tested for their antimicrobial activity on a panel of 14 bacterial strains and the results are summarized in Table [1](#Tab1){ref-type="table"}.Fig. 1Chemical structures of tested compounds. Atalantoflavone (**1)**; 2′-hydroxyatalantoflavone (**2**); neocyclomorusin (**3**); 2-(3,5-dihydroxyphenyl)benzofuran-5,6-diol (**4**); 4-hydroxy-2,6-di-(3′,4′-dimethoxyphenyl)-3,7-dioxabicyclo-(3.3.0)octane (**5**); Candidone (**6**); isoneorautenol (**7**); neobavaisoflavone (**8**); tecleaverdoornine (**9**); maculine (**10**); deacetylnomilin (**11**); daidzein (**12**); isowighteone (**13**); dorstenin (**14**); herranone (**15**); 2-(penta-1,3-diynyl)-5-(3,4-dihydroxybut-1-ynyl)thiophene (**17**); isogarcinol (**16**); ulmoside A (**18**) and 3,4,3′-tri-*O*-methylellagic acid (**19**)Table 1MICs and MBCs (µg/mL) of the nineteen tested compounds and ciprofloxacin on the panel of tested bacteriaSamplesBacterial strains, MIC and MBC (µg/mL)*Escherichia coliEnterobacter aerogenesKlebsiella pneumoniaeProvidencia stuartiiEnterobacter* *cloacaePseudomonas aeruginosa*ATCC 8739AG102AG100 A~tet~ATCC 13048CM64EA27ATCC 11296KP55ATCC29916PS299645BM47BM67PA01PA124**1**256 (--)----256 (--)----------128 (--)--------**2**256 (--)----256 (--)----------256 (--)--------**38** (16)32 (128)32 (128)**8** (16)32 (128)16 (64)**4** (**8**)**8** (16)**8** (32)32 (64)**4** (**8**)16 (128)32 (128)64 (256)**4**256 (--)256 (--)--256 (--)256 (--)256 (--)----256 (--)256 (--)256 (--)------**5**------------------256 (--)--------**64** (32)**8** (16)256 (--)256 (--)256 (--)16 (32)**4** (**8**)**8** (16)16 (128)64 (256)**4**(**8**)256 (--)64 (256)256 (--)**7**256 (--)----256 (--)--------------256 (--)----**88** (32)16 (64)256 (--)128 (--)256 (--)32 (128)**8** (16)**8** (32)**4** (16)**8** (32)**4** (16)256 (--)**8** (32)64 (256)**9**256 (--)--------------------------**10**256 (--)----256 (--)--------------------**11**256 (--)--------------256 (--)----------**12**64 (128)128 (--)128 (--)256 (--)256 (--)128 (--)128 (256)128 (--)64 (256)128 (--)64 (128)256 (--)128 (256)256 (--)**13**128 (--)--128 (--)256 (--)----------256 (--)--------**14**------256 (--)--256 (--)------256 (--)256 (--)256 (--)----**15**128 (--)----256 (--)----------128 (--)256 (--)256 (--)----**16**----------------------------**17**64 (128)128 (--)256 (--)64 (256)256 (--)64 (256)64 (256)128 (--)64 (256)256 (--)256 (--)--256 (--)--**18**------256 (--)----------256 (--)--------**19**64 (256)256 (--)256 (--)128 (--)256 (--)256 (--)64 (256)256 (--)16 (64)32 (256)256 (--)256 (--)----**CHL4** (64)**8** (--)**8** (--)16 (128)--128 (--)16 (128)128 (--)**8** (128)32 (--)--256 (--)16 (256)64 (256)*CHL* chloramphenicol, (--) MIC \> 256 µg/mL, *in bold* significant antibacterial activity (Kuete [@CR15]; Kuete and Efferth [@CR16])Atalantoflavone (**1**); 2′-hydroxyatalantoflavone (**2**); neocyclomorusin (**3**); 2-(3,5-dihydroxyphenyl)benzofuran-5,6-diol (**4**); 4-hydroxy-2,6-di-(3′,4′-dimethoxyphenyl)-3,7-dioxabicyclo-(3.3.0)octane (**5**); Candidone (**6**); isoneorautenol (**7**); neobavaisoflavone (**8**); tecleaverdoornine (**9**); maculine (**10**); deacetylnomilin (**11**); daidzein (**12**); isowighteone (**13**); dorstenin (**14**); herranone (**15**); 2-(penta-1,3-diynyl)-5-(3,4-dihydroxybut-1-ynyl)thiophene (**17**); isogarcinol (**16**); ulmoside A (**18**) and 3,4,3′-tri-*O*-methylellagic acid (**19**). Compound classes \[flavonoids (**1-3, 6, 18**), isoflavonoids (**7, 8, 12, 13**), benzophenone (**16**), benzofuran (**4**), ellagic acid derrivative (**19**), lignan (**5**), alkaloids (**9, 10**), terpenoids (**11, 15**) and thiphene (**19**)\]Bold values indicate Significant activity

Activity of terpenoids {#Sec4}
----------------------

Both diterpenoid (**11**) and triterpenoid (**15**) exhibited very weak activities. Deacetylnomilin (**11**) and herranone (**15**) had detectable MIC values against 2/14 (14.3 %) and 5/14 (35.7 %) bacterial strains respectively (Table [1](#Tab1){ref-type="table"}). However, no minimal bactericidal concentration (MBC) value was obtained with the two terpenoids.

Activity of alkaloids {#Sec5}
---------------------

Furoquinoline alkaloids tecleaverdoornine (**9**) and maculine (**10**) displayed low activity against the tested bacteria. Their inhibitory effects were observed on 1/14 (7.1 %) and 2/14 (14.3 %) microbial strains, respectively, for **9** and **10** (Table [1](#Tab1){ref-type="table"}).

Activity of thiophene {#Sec6}
---------------------

The compound 2-(penta-1,3-diynyl)-5-(3,4-dihydroxybut-1-ynyl)thiophene (**17**) showed MIC values below 100 µg/mL against *Escherichia coli* ATCC 8739, *Enterobacter aerogenes* ATCC 13048 and EA27, *Klebsiella pneumoniae* ATCC11296 and *Providencia stuartii* ATCC29916 (Table [1](#Tab1){ref-type="table"}).

Activity of phenolics (flavonoids, isoflavonoids, benzophenone, benzofuran, coumarins, ellagic acid derrivative and lignan) {#Sec7}
---------------------------------------------------------------------------------------------------------------------------

The best activities were obtained with phenolic compounds; amongst them, flavonoids neocyclomorusin (**3**) and candidone (**6**) as well as isoflavonoids neobavaisoflavone (**8**) and daidzein (**12**) had MIC values ranged from 4 to 256 µg/mL on all the 14 tested bacteria. Moreover, MIC values below 10 µg/mL were obtained with **8**, **3**, **6** and **12** against 7/14 (50 %), 6/14 (42.9 %), 5/14 (35.7 %) and 3/14 (21.4 %) tested bacteria respectively. MIC values below 100 µg/mL were obtained with compound **3** on all tested bacteria. MBC values below 10 µg/mL were also obtained with compound **3** against *K. pneumoniae* ATCC11296 and *Enterobacter cloacae* BM47 whilst values ranged from 8 to 256 µg/mL were noted on all tested pathogens. The lowest MIC value of 4 µg/mL was obtained with compound **3** against *K. pneumoniae* ATCC11296, *E. cloacae* BM47, compound **6** against *E. coli* ATCC8739, *K. pneumoniae* ATCC11296, *E. cloacae* BM47 and compound **8** against *K. pneumoniae* ATCC11296 and *E. cloacae* BM47.

Structure--activity relationship study {#Sec8}
--------------------------------------

When analyzing the structure--activity relationship, it can be observed that terpenoids (both diterpenoids and triterpenoids) as well as the tested furoquinoline alkaloids were poor antimicrobial compounds. A keen look of the activities of phenolics shows that benzophenone (**16**) were not active meanwhile coumarin (**14**), lignan (**5**) and benzofuran (**4**) were also found to be poor antibacterial agents. The best activities were obtained with flavonoids and isoflavonoids. Within flavonoids, it appeared that hydroxylation of compound **1** to yield **2** did not significantly changed the antibacterial activity (Table [1](#Tab1){ref-type="table"}). The presence of a cyclic prenyl moiety in the heterocyclic portion of flavone **3** improves significantly the activity and provides a large antimicrobial selectivity. Regardless the presence of the α,β-unsaturated double bond, compound **6** showed interesting activity like **3.** Compound **6** differs from **1** to **3** with the α,β-unsaturated double bond and its high lipophilicity turning this latter along with **3** as two pharmacophores to be explored for antimicrobial chemotherapy. Nevertheless, the high hydrophilicity of compound **18** reduced drastically its antimicrobial potency (Fig. [2](#Fig2){ref-type="fig"}). Concerning the activity of isoflavonoid, it also appeared that neobavaisoflavone (**8**) was another pharmacophoric moiety (Fig. [3](#Fig3){ref-type="fig"}). Any modification of the structure of compound **8** such as cyclisation or absence of prenyl group resulted in the reduction of antibacterial activity as it can be seen with compounds **7, 12** and **13**.Fig. 2Pharmacophores (**3** and **6**) detected in flavonoidsFig. 3Representation of pharmacophoric scaffold detected in isoflavonoids

Discussion {#Sec9}
==========

Bacterial multidrug resistance represents a major hurdle in the treatment of infectious diseases. In the present study, we tested a panel of bacterial strains including both reference ATCC strains and MDR phenotypes expressing active efflux pumps (Kuete et al. [@CR21], [@CR22]; Fankam et al. [@CR11]). In fact, tripartite drug efflux pumps, mainly those clinically reported as AcrAB--TolC in Enterobacteriaceae or as MexAB--OprM in *Pseudomonas aeruginosa* tested in the present study, play a key role in multidrug resistance of pathogenic Gram-negative bacteria (Nikaido [@CR36]; Davin-Regli et al. [@CR8]). Interestingly, a MIC value of 64 µg/mL was recorded with the best compounds (namely flavonoid **3** and isoflavonoid **8)** against the problematic MDR strain *P. aeruginosa* PA124. This value was identical to that of the reference compound chloramphenicol (Table [1](#Tab1){ref-type="table"}). The antimicrobial activity of a phytochemical has been defined as significant when MIC is below 10 µg/mL, moderate when 10 µg/mL \< MIC \< 100 µg/mL or low when MIC \> 100 µg/mL (Kuete [@CR15]; Kuete and Efferth [@CR16]). In the present study, MIC values below 10 µg/mL were noted with compounds **3**, **6** and **8** against several bacterial strains, highlighting their possible use in the control of bacterial infections. The activity of flavonoid **3** was better or equal to that of chloramphenicol in the majority of the bacteria including all tested *K. pneumoniae, P. stuartii, E. aerogenes, E. cloacae* and *P. aeruginosa* strains (Table [1](#Tab1){ref-type="table"}). This was also the case with compounds **6** and **8** towards the majority of the tested bacterial strains and mostly the MDR phenotypes. Regarding the involvement of MDR bacteria in treatment failures and the re-emergence of infectious diseases (Blot et al. [@CR5]; Falagas and Bliziotis [@CR10]; Nicolle [@CR35]), the activity of flavonoids **3, 6** and isoflavonoid **8** could be considered very promising. *Pseudomonas aeruginosa* is an important nosocomial pathogen highly resistant to clinically used antibiotics, causing a wide spectrum of infections and leading to substantial morbidity and mortality (Cardoso et al. [@CR6]) and was found sensitive to the three compounds (**3, 6** and **8**). MDR Enterobacteriaceae, including *K. pneumoniae*, *E. aerogenes, P. stuartii* and *E. coli*, have also been classified as antimicrobial-resistant organisms of concern in healthcare facilities (Nicolle [@CR35]; Tran et al. [@CR50]). The analysis of data of Table [1](#Tab1){ref-type="table"} shows that MBC/MIC ratios below 4 were recorded with the three best compounds (**3, 6** and **8**) in many cases, suggesting that bacterial effects of these phytochemicals could be expected (Mims et al. [@CR32]; Mbaveng et al. [@CR30], [@CR31]). The data reported herein highlight once more the good pharmacological potential of flavonoids **3, 6** and isoflavonoid **8** and their ability to combat infections involving these bacterial species. Furthermore, the pharmacophoric moiety (**8**) suggests that hemi-synthesis reaction with neobavaisoflavone could be explored in more details for antibacterial drug development. To the best of our knowledge, the antibacterial activity of the best compounds (**3, 6** and **8**) against MDR bacteria is being reported for the first time. However, several flavonoids and isoflavonoids are known to possess antibacterial activities against both drug-sensitive and MDR Gram-negative phenotypes (Kuete et al. [@CR21], [@CR22]; Ndhlala et al. [@CR33]; Ngameni et al. [@CR34]).

Methods {#Sec10}
=======

General procedure {#Sec11}
-----------------

Column chromatography (CC) and thin layer chromatography (TLC) were performed over silica gel 60H (particle size 90 % \<45 mm), 200--300 mesh silica gel silica gel GF254, respectively. 1D- and 2D-NMR spectra were carried out with a Bruker DRX-400 MHz. Melting points were measured by an Electro thermal IA 9000 digital melting point apparatus and are uncorrected.

Plant material {#Sec12}
--------------

Plant species were collected in Yaoundé (Centre Region, Cameroon) and in Dschang (West Region, Cameroon) and identified by the specialist of the national herbarium in Yaoundé, Cameroon where their voucher are kept under the registration codes: *Teclea afzelii* Engl. (Rutaceae) (10674/SRF/Cam), *Erythrina excelsa* Baker (Fabaceae) (61487/HNC), *Erythrina senegalensis* A. Rich. (Fabaceae) (59409/HNC)*, Echinops giganteus* A. Rich. (Asteraceae) (23647/SRF-Cam)*, Pachystela msolo* Engl. (Sapotaceae) (3849/SRFK)*, Garcinia ovalifolia* Oliv. (Guttiferae) (55523/HNC) and *Alchornea laxiflora* (Benth) Pax and Hoff (Euphorbiaceae) (45363HNC).

Ethics statement {#Sec13}
----------------

For the collection of plants, no specific permits were required for the described field studies. For any location/activity, no specific permissions were required. All locations where the plants were collected were not privately-owned or protected in any way and the field studies did not involved endangered or protected species.

Extraction and isolation {#Sec14}
------------------------

Compounds tested in the present work were either previously isolated in our research team (**1--10, 14**) or newly isolated (**12, 13, 15--19**). Compounds **1**--**3** were obtained from the roots of *Milicia excels*a whilst **4** was identified from the leaves as previously reported (Ouete et al. [@CR41], [@CR42]). Compounds **5** and **6** were isolated from *Echinops giganteus* (Asteraceae) (Kuete et al. [@CR24]), while **7** and **8** were obtained from *Erythrina sigmoidea* (Fabaceae) (Kuete et al. [@CR25]). Compounds **9** and **10** were isolated from *Zanthoxylum buesgenii* (Rutaceae) (Sandjo et al. [@CR46]). Compound **14** was isolated from *Dorsteniaelliptica* (Moraceae) (Abegaz et al. [@CR1]).

Compound **11** in addition to **9** and **10** were isolated from the roots of *Teclea afzelii* (Rutaceae); Hence, air-dried roots (7 kg) were macerated in MeOH/DCM (1:1, v/v) for 48 h and the organic (286 g) solid obtained after evaporation of the solvents *in vacuo* was further extracted with hexane (hex, 41 g), ethyl acetate (EA, 44 g) and MeOH (201 g). The EA fraction was purified by column chromatography on silica gel in gradient conditions of hex/EA. Three compounds were isolated as follows: **9** (6 mg), **10** (5 mg) and **11** (10 mg).

Compound **12** was obtained from the roots of *Erythrina excelsa* (2.2 kg) (Fabaceae); The crude extract obtained from the maceration of the air-dried roots was fractioned by silica gel flash chromatography using hex/EA in gradient conditions. The fraction issued from hex/EA (1:1) was chromatographed using the same condition as above from which **12** (45 mg) was isolated. Similarly, **13** (5 mg) was isolated from the roots of *Erythrina senegalensis* (Fabaceae) as described for **12**. Compound **17** (5.0 mg) was isolated from the roots of *Echinops giganteus*; the powdered roots of *E. giganteus* (Asteraceae) was macerated successively in DCM/MeOH (1:1, v/v) and MeOH for 48 h and 24 h, respectively. The organic solutions were pooled together based on their TLC profile. Eighty-one grams of a red dark crude extract were obtained after evaporation *invacuo*. Furthermore, the crude extract was poured onto water and extracted with Hex (A, 10 g), DCM (B, 25 g), EA (C, 30 g), *n*-butanol (D, 5 g). Fraction B was purified on silica gel CC using gradient conditions of Hex/EA and **17** was obtained from the Hex/EA (3:2, v/v). Similarly, bark powder (2.8 kg) of *Pachystela msolo* Engl. (Sapotaceae) was extracted with DCM/MeOH (1:1), yielding a dark crude extract (30 g). The purification of this later in gradient conditions of Hex/EA afforded **15** (5 mg). The stem bark (2.5 kg) of *Garcinia ovalifolia* (Guttiferaceae) was air-dried, ground and macerated in MeOH for 48 h. A brown residue (120 g) was obtained after concentrating the organic solution. Vacuum liquid chromatography was used for a first fractionation with gradient of hex/EA and EA/MeOH. Fractions obtained from Hex and Hex/EA (3:1, v/v) were pooled together (1.22 g) and purified by silica gel CC with gradients of the same mixture of solvents to afford **16** (12 mg). Fractions collected from EA/MeOH (9:1 and 4:1) were also pooled together and purified on silica gel CC with gradients of DCM/MeOH to yield compound **18** (90 mg). The stem bark (1.8 kg) of *Alchornea Laxiflora* (Euphorbiaceae) was macerated in MeOH. The concentrated methanol crude extract (30 g) was subjected to silica gel flash chromatography using Hex (A), EA (B) and MeOH (C). Fraction C (10 g) was purified by silica gel CC using the gradient of DCM/MeOH. Compound **19** (15 mg) was isolated from sub-fractions eluted with DCM/MeOH (95:5).

Antimicrobial assays {#Sec15}
--------------------

### Chemicals for antimicrobial assay {#Sec16}

Chloramphenicol ≥98 % (Sigma-Aldrich, St. Quentin Fallavier, France) was used as reference antibiotics (RA) against Gram-negative bacteria. *p*-Iodonitrotetrazolium chloride ≥97 % (INT, Sigma-Aldrich) was used as microbial growth indicator (Eloff [@CR9]; Mativandlela et al. [@CR29]).

### Microbial strains and culture media {#Sec17}

The studied microorganisms included sensitive and resistant strains of *P. aeruginosa, K. pneumoniae, E. aerogenes, E. cloacae, E. coli, P. stuartii,* obtained from the American Type Culture Collection. Their bacterial features were previously reported (Kuete et al. [@CR22]; Lacmata et al. [@CR27]; Seukep et al. [@CR47]; Touani et al. [@CR49]). Nutrient agar were used for the activation of the tested Gram-negative bacteria (Kuete et al. [@CR23]).

### INT colorimetric assay for MIC and MBC determinations {#Sec18}

The minimal inhibitory concentration (MIC) determinations on the tested bacteria were conducted using rapid *p*-iodonitrotetrazolium chloride (INT) colorimetric assay according to described methods (Eloff [@CR9]) with some modifications (Kuete et al. [@CR19], [@CR20]). The test samples and RA were first of all dissolved in DMSO/Mueller--Hinton Broth (MHB). The final concentration of DMSO was lower than 2.5 % and does not affect the microbial growth (Kuete et al. [@CR17], [@CR18]). The solution obtained was then added to Mueller--Hinton Broth, and serially diluted two fold (in a 96-wells microplate). One hundred microlitre (100 µL) of inoculum 1.5 × 10^6^ CFU/mL prepared in appropriate broth was then added (Kuete et al. [@CR19], [@CR20]). The plates were covered with a sterile plate sealer, then agitated to mix the contents of the wells using a plate shaker and incubated at 37 °C for 18 h. The assay was repeated thrice. Wells containing adequate broth, 100 µL of inoculum and DMSO to a final concentration of 2.5 % served as negative control. The MIC of samples was detected after 18 h incubation at 37 °C, following addition (40 µL) of 0.2 mg/mL of INT and incubation at 37 °C for 30 min. Viable bacteria reduced the yellow dye to a pink. MIC was defined as the sample concentration that prevented the color change of the medium and exhibited complete inhibition of microbial growth (Eloff [@CR9]). The minimal bactericidal concentration (MBC) was determined by adding 50 µL aliquots of the preparations, which did not show any growth after incubation during MIC assays, to 150 µL of adequate broth. These preparations were incubated at 37 °C for 48 h. The MBC was regarded as the lowest concentration of extract, which did not produce a color change after addition of INT as mentioned above (Kuete et al. [@CR19], [@CR20]).

Conclusion {#Sec19}
==========

Regarding the medical importance of the studied microorganisms, the results obtained and reported in this study interestingly showed how secondary metabolites are still a strong source of inspiration in drug discovery. Thus, the present data provided evidence that neocyclomorusin (**3**), candidone (**6**) and neobavaisoflavone (**8**) could be potential antimicrobial drugs to fight MDR bacterial infections and could also be used as motifs for developing related antibiotics with strong potency. To explore more the therapeutic values of the studied compounds, a combination with commonly used antibiotics will be further performed. Also, the study of the mechanism of action of the effective compounds will be carried out to better understand their inhibitory effects.
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